APAC Scar Treatment Market

APAC Scar Treatment Market Size (2023 to 2028)

The Asia Pacific Scar Treatment Market was worth USD 4.25 billion in 2023. It is projected to reach USD 7.18 billion by 2028, growing at a CAGR of 11.05% during the forecast period.

Treatment of scars can never remove scars permanently but can reduce their appearance and make them less visible. Therefore, much research is required to make the existing treatment more effective and efficient. In addition, treatments like laser procedures involve side effects that need consideration and advancement.

The increasing incidence of burn cases and rising demand for minimally invasive procedures drive the APAC to the burn care market. In addition, the market is witnessing substantial growth due to the rising incidence of skin-related diseases among all age groups and the rise in personal care expenditure.

The scar treatment market in the APAC region is further driven by the growing desire among individuals to improve their visual appeal and undergo comprehensive skin rejuvenation. Most of the demand comes from women, who are more concerned about their appearance. A rise in the incidence of hypertrophic burn markings, which distort the victim's look, is also driving up demand for the APAC scar treatment market.  India and China are two of the most important countries in the Asia-Pacific market. The majority of countries in this region are developing economies that are accelerating their technological adoption. Increased R&D investment by major multinational corporations in these countries has proven to be a significant driver of the region's industries.

Scar treatments are becoming more popular, increasing the demand for related products and services in the region. The popularity of over-the-counter (OTC) scar therapy medicines is growing due to their cheaper cost than prescription medications. Furthermore, improved laser treatments and operations for all types of scars are now available, with comparable results. The increased aesthetic sensibility of the general public has resulted in the widespread use of skin treatment treatments.

In addition, increased access to dermatological facilities and the launch of treatments comprising both chemical and natural ingredients are driving up demand for the service. Increased demand for sterile pads to stop blood flow and treat the wound area with disinfectants, rising demand for iodopovidone to disinfect healthcare personnel's hands, and expanding investment by key companies to create enhanced scar dressings are all expected to drive the market forward. Due to a growing focus on personal well-being among the general population, rising disposable income, and rising prevalence of skin-related problems such as burns and wounds, as well as an increase in the number of cosmetic procedures performed in the region, the Asia-Pacific scar treatment market is expected to grow at a faster rate than other regions.

However, market growth is expected to be hindered due to the side effects of the treatment and the high costs of advanced scar treatment procedures. On the other hand, the expansion of the Scar treatment market in the Asia-Pacific region is higher than in developed areas because of improving healthcare facilities and an increase in population.

This research report on the European scar treatment market has been segmented and sub-segmented into the following categories:

By Treatment Type:

• Topical treatment
  • Creams
  • Oils
  • Gels
• Gel Sheets
  • Surface Treatment
  • Dermabrasion
  • Chemical Peeling
  • Cryosurgery
• Laser Treatment
• Injectable Treatment
  • Tissue Fillers
  • Steroid Injections
• Invasive Surgical Treatment

By Scar Type:

• Keloid and Hypertrophic Scars
• Contracture Scars
• Acne Scars
• Stretch Scars
• Post-Surgical Scars

By End User:

• Hospitals
• private clinics
• pharmacies & drug stores
• E-Commerce

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The Asia Pacific (APAC) Scar Treatment Market is rising as many patients participate in the treatment prescribing process. It is a vital attribute adopted by famous doctors in the market. It can lead to a significant increase in compliance with prescription treatment effectiveness. China, South Korea, India, Japan, and others are tremendous contributors to the Asia Pacific scar treatment market.

With the increasing supply of technologically advanced products and many manufacturers in countries such as China, the Asia Pacific region is expected to achieve the fastest CAGR during the forecast period. In addition, emerging economies offer laser equipment at a low cost, which increases the popularity of laser equipment and accelerates the Asia Pacific market expansion. Furthermore, India has contributed significantly to the APAC Scar Treatment Market's growth due to the high rate of burns.

The Indian scar treatment market occupies the highest market share due to the increasing incidence of burn cases. India makes a record in burn injuries with 70 lakh burn injury cases every year, of which 1.4 lakh people die of burns annually. More than 70% of all burn injuries find in the most productive age group. About four out of five burnt cases are women and children in India, which is anticipated to drive the market's growth. In India, there is also a large amount of electrical burn due to farmers getting considerable electric injury during the agriculture phase as long as they get electricity from the mainline to pump water to the farm.

The Japanese scar treatment market shows ideal market growth in the Asia Pacific burns care market due to the rising awareness level of people about the availability of various treatment options for scar management, which is expected to propel the market growth in Japan. In addition, increasing healthcare expenditure and incidence of burn cases are expected to drive market growth in this region.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the Asia Pacific scar treatment market profiled in the report are Oculus Innovative Sciences Inc., Smith & Nephew PLC, Nutramarks Inc., Merz Inc., Enaltus LLC, CCA Industries Inc., Cynosure Inc., Syneron Medical Ltd, Mölnlycke Health Care, Avita Medical Limited, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd, AC. Alma Lasers, Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Company Limited.